Position in NVAX
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$6,622,315
+$6,583,626 QoQ
Shares Held
703,006
+14690.8% QoQ
Ownership
0.426%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#24
of 263 holders
Holding Since
Mar 2020
21 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVAX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026FEDERATED HERMES, INC. holds $2,455,215,104 across 149 Biotechnology names. NVAX ranks #62 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
719,905 | $216,713,000 | |
| 2 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
1,785,716 | $198,268,046 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
256,884 | $160,177,448 | |
| 4 | MRNA |
Moderna, Inc.
|
1,794,778 | $125,688,301 | |
| 5 | KYMR |
Kymera Therapeutics, Inc.
|
749,398 | $85,933,468 | |
| 6 | EYPT |
EyePoint, Inc.
|
5,681,052 | $81,239,042 | |
| 7 | ARGX |
Argenx SE
|
87,288 | $80,983,187 | |
| 8 | ZBIO |
Zenas BioPharma, Inc.
|
3,116,805 | $79,104,510 |
All Filings in NVAX
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,622,315 | 703,006 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $38,689 | 4,753 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $20,784 | 3,093 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $5,999 | 692 | Shares | Defined | 2025-11-03 | |
| 2025-03-31 | $359,754 | 56,124 | Shares | Defined | 2025-05-08 | |
| 2024-12-31 | $406,068 | 50,506 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $611,064 | 48,382 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $625,758 | 49,428 | Shares | Defined | 2024-08-08 | |
| 2024-03-31 | $216,930 | 45,383 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $253,022 | 52,713 | Shares | Defined | 2024-01-31 | |
| 2023-09-30 | $3,343,627 | 461,827 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $1,644,355 | 221,313 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $552,133 | 79,673 | Shares | Defined | 2023-05-08 | |
| 2022-12-31 | $199,935 | 19,449 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $77,641 | 4,266 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $293,768 | 5,712 | Shares | Defined | 2022-09-16 | |
| 2022-03-31 | $2,385,449 | 32,389 | Shares | Defined | 2022-05-13 | |
| 2021-03-31 | $627,513 | 3,461 | Shares | Defined | 2021-05-13 | |
| 2020-09-30 | $2,548,283 | 23,519 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $6,366,189 | 76,379 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $387,301 | 28,520 | Shares | Defined | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||